Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a €84.00 ($98.82) target price by analysts at Deutsche Bank AG in a research report issued to clients and investors on Tuesday. The firm currently has a “neutral” rating on the stock.

Several other brokerages also recently weighed in on FME. Nord/LB set a €93.00 ($109.41) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, May 4th. J P Morgan Chase & Co set a €104.50 ($122.94) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, May 4th. S&P Global set a €88.00 ($103.53) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Wednesday, May 3rd. Kepler Capital Markets set a €95.00 ($111.76) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Wednesday, May 3rd. Finally, Commerzbank Ag set a €88.00 ($103.53) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Wednesday, May 3rd. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and ten have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of €88.02 ($103.56).

Shares of Fresenius Medical Care AG & Co. KGaA (ETR FME) opened at 78.024 on Tuesday. The company has a market capitalization of €23.94 billion and a PE ratio of 20.120. The stock has a 50 day moving average price of €83.68 and a 200-day moving average price of €81.11. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €70.82 and a 12 month high of €89.07.

COPYRIGHT VIOLATION WARNING: This story was first reported by Daily Political and is the property of of Daily Political. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this story can be read at https://www.dailypolitical.com/2017/08/07/deutsche-bank-ag-reiterates-84-00-price-target-for-fresenius-medical-care-ag-co-kgaa-fme.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.